je.st
news
RPT-Market Chatter-Corporate finance press digest
2014-05-01 23:33:21| Biotech - Topix.net
* Merck & Co Inc is considering selling a big portfolio of mature drugs that could fetch more than $15 billion, according to people familiar with the matter, as the U.S. drugmaker continues to streamline businesses to focus on high-growth areas.
Tags: press
finance
digest
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|